Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States

    J. Quentin Clemens, Howard B. Goldman, Kelly H. Zou, Xuemei Luo, David Russell, Douglass Chapman, Canan B. Esinduy, Jennifer T. Anger
    Studysummary In this study, the authors observed that treatment patterns for new benign prostatic hyperplasia largely aligned with guidelines, but 5-α reductase inhibitors were used inappropriately based on prostate size as indicated by prostate specific antigen.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results